TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.780
+0.150 (3.24%)
At close: Oct 7, 2025, 4:00 PM EDT
4.860
+0.080 (1.67%)
Pre-market: Oct 8, 2025, 8:00 AM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $238.37 million as of October 8, 2025. Its market cap has increased by 81.52% in one year.
Market Cap
238.37M
Enterprise Value
245.54M
1-Year Change
81.52%
Ranking
Category
Stock Price
$4.78
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $238.37M, a decrease of -27.49%. That is a compound annual growth rate of -6.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 238.37M | 56.03% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | 328.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |